Acadia Pharmaceuticals Inc (ACAD)
Depreciation & Amortization
$12.02M
TTM · Period ending: · USD
ACAD Depreciation & Amortization
Latest reported$12.02Mperiod ending
Latest reported$12.02Mperiod ending
ACAD TTM Depreciation & Amortization ($1.31M → $12.02M)
TTM Depreciation & Amortization
High-resolution chart · PNG
ACAD depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 12,024,000 | |
| 11,802,000 | |
| 11,760,000 | |
| 14,050,000 | |
| 13,670,000 | |
| 13,306,000 | |
| 15,883,000 | |
| 12,306,000 | |
| 11,459,000 | |
| 10,654,000 | |
| 5,552,000 | |
| 4,404,000 | |
| 3,187,000 | |
| 1,936,000 | |
| 2,026,000 | |
| 2,072,000 | |
| 2,551,000 | |
| 2,965,000 | |
| 3,344,000 | |
| 3,647,000 | |
| 3,369,000 | |
| 3,163,000 | |
| 2,932,000 | |
| 2,729,000 | |
| 2,673,000 | |
| 2,645,000 | |
| 2,766,000 | |
| 2,913,000 | |
| 3,013,000 | |
| 3,029,000 | |
| 3,005,000 | |
| 2,924,000 | |
| 2,870,000 | |
| 2,835,000 | |
| 2,713,000 | |
| 2,642,000 | |
| 2,555,000 | |
| 2,329,000 | |
| 1,828,000 | |
| 1,326,000 | |
| 833,000 | |
| 663,000 | |
| 647,000 | |
| 580,000 | |
| 523,000 | |
| 285,000 | |
| 206,000 | |
| 184,000 | |
| 140,000 | |
| 110,000 | |
| 79,000 | |
| 61,000 | |
| 74,000 | |
| 91,000 | |
| 109,000 | |
| 118,000 | |
| 119,000 | |
| 126,000 | |
| 285,000 | |
| 449,000 | |
| 520,000 | |
| 622,000 | |
| 607,000 | |
| 857,000 | |
| 975,000 | |
| 1,060,000 | |
| 1,111,000 | |
| 252,000 | |
| 813,000 | |
| 1,105,000 | |
| 1,043,000 | |
| 2,202,000 | |
| 1,421,000 | |
| 526,000 | |
| 768,000 | |
| -725,000 | |
| -505,000 | |
| 70,000 | |
| -146,000 | |
| 809,200 | |
| 811,000 | |
| 908,600 | |
| 1,025,600 | |
| 1,176,700 | |
| 1,261,200 | |
| 1,277,000 | |
| 1,305,600 |